Ontology highlight
ABSTRACT:
SUBMITTER: Montoya MC
PROVIDER: S-EPMC6299222 | biostudies-other | 2018 Dec
REPOSITORIES: biostudies-other
mBio 20181218 6
The concept of repurposing previously approved medications to the treatment of new indications by taking advantage of off-target effects has gained traction in recent years, particularly in areas of medicine that do not offer large profits to pharmaceutical firms. As infectious disease discovery research has declined among large pharmaceutical companies, the potential payoff of repurposing has become attractive. From these efforts, the triphenylethylene class of selective estrogen receptor modul ...[more]